drugset / Trial / NCT04241393
An Open-label Trial to Evaluate Mass Balance of Tavapadon at Steady State in Healthy Subjects
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this trial is to determine the absorption, metabolism, and excretion (AME) of \[14C\] tavapadon.
Timeline
- Start
- 2020-02-04
- Primary completion
- 2020-11-08
- Completion
- 2020-11-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tavapadon | Small molecule | 2.5 mg | Oral |
Indications
No indication recorded.